Design of active small interfering RNAs

Current Opinion in Molecular Therapeutics

Volumn 9, Issue 2, 2007, Pages 110-118

  Peek, Andrew S ^a   Behlke, Mark A ^a  

^a INTEGRATED DNA TECHNOLOGIES   (United States)

Author keywords

Algorithm; Innate immunity; Oligonucleotides; RNA interference; Small interfering RNA

Indexed keywords

INTERFERON; SMALL INTERFERING RNA; TRANSCRIPTOME;

ALGORITHM; ALLELE; CHEMICAL MODIFICATION; CROSS HYBRIDIZATION; DNA BASE COMPOSITION; GENE LIBRARY; GENE SEQUENCE; GENE TARGETING; GENETIC STABILITY; IMMUNE SYSTEM; INNATE IMMUNITY; INTERFERON INDUCTION; REVIEW; RNA STRUCTURE; SEQUENCE HOMOLOGY; THERMODYNAMICS;

ANIMALS; HUMANS; IMMUNITY, NATURAL; INTERFERONS; NUCLEIC ACID CONFORMATION; RNA, SMALL INTERFERING;

EID: 34247272091     PISSN: 14648431     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (104)

1. Mello CC, Conte D Jr: Revealing the world of RNA interference. Nature (2004) 431(7006):338-342.
2. Meister G, Tuschl T: Mechanisms of gene silencing by double-stranded RNA. Nature (2004) 431(7006):343-349.
3. Hannon GJ, Rossi JJ: Unlocking the potential of the human genome with RNA interference. Nature (2004) 431(7006):371-378.
4. Sontheimer EJ: Assembly and function of RNA silencing complexes. Nat Rev Mol Cell Biol (2005) 6(2):127-138.
5. Collins RE, Cheng X: Structural and biochemical advances in mammalian RNAi. J Cell Biochem (2006) 99(5):1251-1266.
6. Elbashir SM, Martinez J, Patkaniowska A, Lendeckel W, Tuschl T: Functional anatomy of siRNAs for mediating efficient RNAi in Drosophila melanogaster embryo lysate. EMBO J (2001) 20(23):6877-6888.
7. Hohjoh H: RNA interference (RNAi) induction with various types of synthetic oligonucleotide duplexes in cultured human cells. FEBS Lett (2002) 521(1-3):195-199.
8. Boutla A, Delidakis C, Livadaras I, Tabler M: Variations of the 3′ protruding ends in synthetic short interfering RNA (siRNA) tested by microinjection in Drosophila embryos. Oligonucleotides (2003) 13(5):295-301.
9. Aza-Blanc P, Cooper CL, Wagner K, Batalov S, Deveraux QL, Cooke MP: Identification of modulators of TRAIL-induced apoptosis via RNAi-based phenotypic screening. Mol Cell (2003) 12(3):627-637. • This study was the first to demonstrate thermodynamic asymmetry for functional siRNAs.
10. Khvorova A, Reynolds A, Jayasena SD: Functional siRNAs and miRNAs exhibit strand bias. Cell (2003) 115(2):209-216.
11. Schwarz DS, Hutvagner G, Du T, Xu Z, Aronin N, Zamore PD: Asymmetry in the assembly of the RNAi enzyme complex. Cell (2003) 115(2):199-208.
12. Tomari Y, Matranga C, Haley B, Martinez N, Zamore PD: A protein sensor for siRNA asymmetry. Science (2004) 306(5700):1377-1380.
13. Hohjoh H: Enhancement of RNAi activity by improved siRNA duplexes. FEBS Lett (2004) 557(1-3):193-198.
14. Holen T, Moe SE, Sorbo JG, Meza TJ, Ottersen OP, Klungland A: Tolerated wobble mutations in siRNAs decrease specificity, but can enhance activity in vivo. Nucleic Acids Res (2005) 33(15):4704-4710.
15. Haley B, Zamore PD: Kinetic analysis of the RNAi enzyme complex. Nat Struct Mol Biol (2004) 11(7):599-606.
16. Holen T: Mechanism of RNAi:mRNA cleavage fragments may indicate stalled RISC. J RNAi Gene Silencing (2005) 1(1):21-25.
17. Vickers TA, Koo S, Bennett CF, Crooke ST, Dean NM, Baker BF: Efficient reduction of target RNAs by small interfering RNA and RNase H-dependent antisense agents. A comparative analysis. J Biol Chem (2003) 278(9):7108-7118.
18. Xu Y, Zhang HY, Thormeyer D, Larsson O, Du Q, Elmen J, Wahlestedt C, Liang Z: Effective small interfering RNAs and phosphorothioate antisense DNAs have different preferences for target sites in the luciferase mRNAs. Biochem Biophys Res Commun (2003) 306(3):712-717.
19. Kretschmer-Kazemi Far R, Sczakiel G: The activity of siRNA in mammalian cells is related to structural target accessibility: A comparison with antisense oligonucleotides. Nucleic Acids Res (2003) 31(15):4417-4424.
20. Bohula EA, Salisbury AJ, Sohail M, Playford MP, Riedemann J, Southern EM, Macaulay VM: The efficacy of small interfering RNAs targeted to the type 1 insulin-like growth factor receptor (IGF1R) is influenced by secondary structure in the IGF1R transcript. J Biol Chem (2003) 278(18):15991- 15997.
21. Overhoff M, Alken M, Far RK, Lemaitre M, Lebleu B, Sczakiel G, Robbins I: Local RNA target structure influences siRNA efficacy: A systematic global analysis. J Mol Biol (2005) 348(4):871-881.
22. Schubert S, Grunweller A, Erdmann VA, Kurreck J: Local RNA target structure influences siRNA efficacy: Systematic analysis of intentionally designed binding regions. J Mol Biol (2005) 348(4):883-893.
23. Brown KM, Chu CY, Rana TM: Target accessibility dictates the potency of human RISC. Nat Struct Mol Biol (2005) 12(5):469-470.
24. Westerhout EM, Ooms M, Vink M, Das AT, Berkhout B: HIV-1 can escape from RNA interference by evolving an alternative structure in its RNA genome. Nucleic Acids Res (2005) 33(2):796-804.
25. Patzel V, Rutz S, Dietrich I, Koberle C, Scheffold A, Kaufmann SH: Design of siRNAs producing unstructured guide-RNAs results in improved RNA interference efficiency. Nat Biotechnol (2005) 23(11):1440- 1444.
26. Luo KQ, Chang DC: The gene-silencing efficiency of siRNA is strongly dependent on the local structure of mRNA at the targeted region. Biochem Biophys Res Commun (2004) 318(1):303-310.
27. Heale BS, Soifer HS, Bowers C, Rossi JJ: siRNA target site secondary structure predictions using local stable substructures. Nucleic Acids Res (2005) 33(3):e30.
28. Yiu SM, Wong PW, Lam TW, Mui YC, Kung HF, Lin M, Cheung YT: Filtering of ineffective siRNAs and improved siRNA design tool. Bioinformatics (2005) 21(2):144-151.
29. Martinez LA, Naguibneva I, Lehrmann H, Vervisch A, Tchenio T, Lozano G, Harel-Bellan A: Synthetic small inhibiting RNAs: Efficient tools to inactivate oncogenic mutations and restore p53 pathways. Proc Natl Acad Sci USA (2002) 99(23):14849-14854.
30. Amarzguioui M, Holen T, Babaie E, Prydz H: Tolerance for mutations and chemical modifications in a siRNA. Nucleic Acids Res (2003) 31(2):589-595.
31. Du Q, Thonberg H, Wang J, Wahlestedt C, Liang Z: A systematic analysis of the silencing effects of an active siRNA at all single-nucleotide mismatched target sites. Nucleic Acids Res (2005) 33(5):1671-1677. • This study examined the specificity of an siRNA by keeping the siRNA constant and systematically changing the target sequence at every possible position with every possible base change and is a useful guide to predict cross-reactivity and help design allele-specific siRNAs.
32. Miller VM, Xia H, Marrs GL, Gouvion CM, Lee G, Davidson BL, Paulson HL: Allele-specific silencing of dominant disease genes. Proc Natl Acad Sci USA (2003) 100(12):7195-7200.
33. Miller VM, Gouvion CM, Davidson BL, Paulson HL: Targeting Alzheimer's disease genes with RNA interference: An efficient strategy for silencing mutant alleles. Nucleic Acids Res (2004) 32(2):661-668.
34. Dykxhoorn DM, Schlehuber LD, London IM, Lieberman J: Determinants of specific RNA interference-mediated silencing of human β-globin alleles differing by a single nucleotide polymorphism. Proc Natl Acad Sci USA (2006) 103(15):5953-5958.
35. Schwarz DS, Ding H, Kennington L, Moore JT, Schelter J, Burchard J, Linsley PS, Aronin N, Xu Z, Zamore PD: Designing siRNA that distinguish between genes that differ by a single nucleotide. PLoS Genet (2006) 2(9):e140. • This study focused on design approaches to make allele-specific siRNAs by fixing the polymorphic site and varying the siRNA and is a useful guide to predict cross-reactivity and help design allele-specific siRNAs.
36. Jackson AL, Bartz SR, Schelter J, Kobayashi SV, Burchard J, Mao M, Li B, Cavet G, Linsley PS: Expression profiling reveals off-target gene regulation by RNAi. Nat Biotechnol (2003) 21(6):635-637. • This study first demonstrated the magnitude of the off-target silencing problem on a genome-wide scale.
37. Persengiev SP, Zhu X, Green MR: Nonspecific, concentrationdependent stimulation and repression of mammalian gene expression by small interfering RNAs (siRNAs). RNA (2004) 10(1):12-18.
38. Scacheri PC, Rozenblatt-Rosen O, Caplen NJ, Wolfsberg TG, Umayam L, Lee JC, Hughes CM, Shanmugam KS, Bhattacharjee A, Meyerson M, Collins FS: Short interfering RNAs can induce unexpected and divergent changes in the levels of untargeted proteins in mammalian cells. Proc Natl Acad Sci USA (2004) 101(7):1892-1897.
39. Doench JG, Sharp PA: Specificity of microRNA target selection in translational repression. Genes Dev (2004) 18(5):504-511.
40. Lim LP, Lau NC, Garrett-Engele P, Grimson A, Schelter JM, Castle J, Bartel DP, Linsley PS, Johnson JM: Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature (2005) 433(7027):769-773.
41. Lin X, Ruan X, Anderson MG, McDowell JA, Kroeger PE, Fesik SW, Shen Y: siRNA-mediated off-target gene silencing triggered by a 7 nt complementation. Nucleic Acids Res (2005) 33(14):4527-4535.
42. Jackson AL, Burchard J, Schelter J, Chau BN, Cleary M, Lim L, Linsley PS: Widespread siRNA "off-target" transcript silencing mediated by seed region sequence complementarity. RNA (2006) 12(7):1179- 1187.
43. Birmingham A, Anderson EM, Reynolds A, Ilsley-Tyree D, Leake D, Fedorov Y, Baskerville S, Maksimova E, Robinson K, Karpilow J, Marshall WS, Khvorova A: 3′ UTR seed matches, but not overall identity, are associated with RNAi off-targets. Nat Methods (2006) 3(3):199-204.
44. Jackson AL, Burchard J, Leake D, Reynolds A, Schelter J, Guo J, Johnson JM, Lim L, Karpilow J, Nichols K, Marshall W et al: Position-specific chemical modification of siRNAs reduces "off-target" transcript silencing. RNA (2006) 12(7):1197-1205.
45. Cullen BR: Enhancing and confirming the specificity of RNAi experiments. Nat Methods (2006) 3(9):677-681.
46. Echeverri CJ, Beachy PA, Baum B, Boutros M, Buchholz F, Chanda SK, Downward J, Ellenberg J, Fraser AG, Hacohen N, Hahn WC et al: Minimizing the risk of reporting false positives in large-scale RNAi screens. Nat Methods (2006) 3(10):777-779.
47. Czauderna F, Fechtner M, Dames S, Aygun H, Klippel A, Pronk GJ, Giese K, Kaufmann J: Structural variations and stabilising modifications of synthetic siRNAs in mammalian cells. Nucleic Acids Res (2003) 31(11):2705-2716.
48. Allerson CR, Sioufi N, Jarres R, Prakash TP, Naik N, Berdeja A, Wanders L, Griffey RH, Swayze EE, Bhat B: Fully 2′-modified oligonucleotide duplexes with improved in vitro potency and stability compared to unmodified small interfering RNA. J Med Chem (2005) 48(4):901-904.
49. Prakash TP, Allerson CR, Dande P, Vickers TA, Sioufi N, Jarres R, Baker BF, Swayze EE, Griffey RH, Bhat B: Positional effect of chemical modifications on short interference RNA activity in mammalian cells. J Med Chem (2005) 48(13):4247-4253.
50. Kraynack BA, Baker BF: Small interfering RNAs containing full 2′-O-methylribonucleotide-modified sense strands display Argonaute2/eIF2C2-dependent activity. RNA (2006) 12(1):163- 176.
51. Chen D, Texada DE, Duggan C, Liang C, Reden TB, Kooragayala LM, Langford MP: Surface calreticulin mediates muramyl dipeptide-induced apoptosis in RK13 cells. J Biol Chem (2005) 280(23):22425-22436.
52. Soutschek J, Akinc A, Bramlage B, Charisse K, Constien R, Donoghue M, Elbashir S, Geick A, Hadwiger P, Harborth J, Kesavan JM et al: Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs. Nature (2004) 432(7014):173-178.
53. Vermeulen A, Behlen L, Reynolds A, Wolfson A, Marshall WS, Karpilow J, Khvorova A: The contributions of dsRNA structure to Dicer specificity and efficiency. RNA (2005) 11(5):674-682.
54. Kim DH, Behlke MA, Rose SD, Chang MS, Choi S, Rossi JJ: Synthetic dsRNA Dicer substrates enhance RNAi potency and efficacy. Nat Biotechnol (2005) 23(2):222-226.
55. Rose SD, Kim DH, Amarzguioui M, Heidel JD, Collingwood MA, Davis ME, Rossi JJ, Behlke MA: Functional polarity is introduced by Dicer processing of short substrate RNAs. Nucleic Acids Res (2005) 33(13):4140- 4156.
56. Reynolds A, Anderson EM, Vermeulen A, Fedorov Y, Robinson K, Leake D, Karpilow J, Marshall WS, Khvorova A: Induction of the interferon response by siRNA is cell type- and duplex length-dependent. RNA (2006) 12(6):988-993.
57. Amarzguioui M, Rossi JJ, Kim D: Approaches for chemically synthesized siRNA and vector-mediated RNAi. FEBS Lett (2005) 579(26):5974- 5981.
58. Marques JT, Devosse T, Wang D, Zamanian-Daryoush M, Serbinowski P, Hartmann R, Fujita T, Behlke MA, Williams BR: A structural basis for discriminating between self and nonself double-stranded RNAs in mammalian cells. Nat Biotechnol (2006) 24(5):559-565.
59. Amarzguioui M, Lundberg P, Cantin E, Hagstrom JE, Behlke MA, Rossi JJ: Rational design and in vitro and in vivo delivery of Dicer substrate siRNA. Nat Protocols (2006) 1(2):508-517.
60. Matteucci M: Oligonucleotide analogues: An overview. Ciba Found Symp (1997) 209:5-14; discussion 14-18.
61. Manoharan M: Oligonucleotide conjugates as potential antisense drugs with improved uptake, biodistribution, targeted delivery, and mechanism of action. Antisense Nucleic Acid Drug Dev (2002) 12(2):103-128.
62. Eder PS, Dagle JM, Walder JA: Substrate specificity and kinetics of degradation of antisense oligonucleotides by a 3′ exonuclease in plasma. Antisense Res Dev (1991) 1(2):141-151.
63. Kennedy S, Wang D, Ruvkun G: A conserved siRNA-degrading RNase negatively regulates RNA interference in C. elegans. Nature (2004) 427(6975):645-649.
64. Hall AH, Wan J, Shaughnessy EE, Ramsay Shaw B, Alexander KA: RNA interference using boranophosphate siRNAs: Structure-activity relationships. Nucleic Acids Res (2004) 32(20):5991-6000.
65. Hall AH, Wan J, Spesock A, Sergueeva Z, Shaw BR, Alexander KA: High potency silencing by single-stranded boranophosphate siRNA. Nucleic Acids Res (2006) 34(9):2773-2781.
66. Harborth J, Elbashir SM, Vandenburgh K, Manninga H, Scaringe SA, Weber K, Tuschl T: Sequence, chemical, and structural variation of small interfering RNAs and short hairpin RNAs and the effect on mammalian gene silencing. Antisense Nucleic Acid Drug Dev (2003) 13(2):83-105.
67. Chiu YL, Rana TM: siRNA function in RNAi: A chemical modification analysis. RNA (2003) 9(9):1034-1048.
68. Braasch DA, Jensen S, Liu Y, Kaur K, Arar K, White MA, Corey DR: RNA interference in mammalian cells by chemically-modified RNA. Biochemistry (2003) 42(26):7967-7975.
69. Choung S, Kim YJ, Kim S, Park HO, Choi YC: Chemical modification of siRNAs to improve serum stability without loss of efficacy. Biochem Biophys Res Commun (2006) 342(3):919-927.
70. Morrissey DV, Blanchard K, Shaw L, Jensen K, Lockridge JA, Dickinson B, McSwiggen JA, Vargeese C, Bowman K, Shaffer CS, Polisky BA, Zinnen S: Activity of stabilized short interfering RNA in a mouse model of hepatitis B virus replication. Hepatology (2005) 41(6):1349-1356.
71. Morrissey DV, Lockridge JA, Shaw L, Blanchard K, Jensen K, Breen W, Hartsough K, Machemer L, Radka S, Jadhav V, Vaish N et al: Potent and persistent in vivo anti-HBV activity of chemically modified siRNAs. Nat Biotechnol (2005) 23(8):1002-1007.
72. Grunweller A, Wyszko E, Bieber B, Jahnel R, Erdmann VA, Kurreck J: Comparison of different antisense strategies in mammalian cells using locked nucleic acids, 2′-O-methyl RNA, phosphorothioates and small interfering RNA. Nucleic Acids Res (2003) 31(12):3185- 3193.
73. Elmen J, Thonberg H, Ljungberg K, Frieden M, Westergaard M, Xu Y, Wahren B, Liang Z, Orum H, Koch T, WahLestedt C: Locked nucleic acid (LNA) mediated improvements in siRNA stability and functionality. Nucleic Acids Res (2005) 33(1):439-447.
74. Juliano RL: Peptide-oligonucleotide conjugates for the delivery of antisense and siRNA. Curr Opin Mol Ther (2005) 7(2):132-136.
75. Marques JT, Williams BR: Activation of the mammalian immune system by siRNAs. Nat Biotechnol (2005) 23(11):1399-1405.
76. Schlee M, Hornung V, Hartmann G: siRNA and isRNA: Two edges of one sword. Mol Ther (2006) 14(4):463-470.
77. Sioud M, Sorensen DR: Cationic liposome-mediated delivery of siRNAs in adult mice. Biochem Biophys Res Commun (2003) 312(4):1220- 1225.
78. Sioud M: Induction of inflammatory cytokines and interferon responses by double-stranded and single-stranded siRNAs is sequence-dependent and requires endosomal localization. J Mol Biol (2005) 348(5):1079-1090.
79. Ma Z, Li J, He F, Wilson A, Pitt B, Li S: Cationic lipids enhance siRNA-mediated interferon response in mice. Biochem Biophys Res Commun (2005) 330(3):755-759.
80. Robbins MA, Li M, Leung I, Li H, Boyer DV, Song Y, Behlke MA, Rossi JJ: Stable expression of shRNAs in human CD34+ progenitor cells can avoid induction of interferon responses to siRNAs in vitro. Nat Biotechnol (2006) 24(5):566-571.
81. Heidel JD, Hu S, Liu XF, Triche TJ, Davis ME: Lack of interferon response in animals to naked siRNAs. Nat Biotechnol (2004) 22(12):1579-1582.
82. Kariko K, Buckstein M, Ni H, Weissman D: Suppression of RNA recognition by toll-like receptors: The impact of nucleoside modification and the evolutionary origin of RNA. Immunity (2005) 23(2):165-175. • This study first identified the spectrum of base modifications that enable RNA sequences to evade detection by receptors of the innate immune system.
83. Judge AD, Bola G, Lee AC, MacLachlan I: Design of noninflammatory synthetic siRNA mediating potent gene silencing in vivo. Mol Ther (2006) 13(3):494-505. • This study first identified the minimal modification patterns necessary for 2′-O-methyl modified RNAs to evade detection by receptors of the innate immune system.
84. Elbashir SM, Harborth J, Weber K, Tuschl T: Analysis of gene function in somatic mammalian cells using small interfering RNAs. Methods (2002) 26(2):199-213.
85. Holen T, Amarzguioui M, Wiiger MT, Babaie E, Prydz H: Positional effects of short interfering RNAs targeting the human coagulation trigger tissue factor. Nucleic Acids Res (2002) 30(8):1757-1766.
86. Reynolds A, Leake D, Boese Q, Scaringe S, Marshall WS, Khvorova A: Rational siRNA design for RNA interference. Nat Biotechnol (2004) 22(3):326-330.
87. Ui-Tei K, Naito Y, Takahashi F, Haraguchi T, Ohki-Hamazaki H, Juni A, Ueda R, Saigo K: Guidelines for the selection of highly effective siRNA sequences for mammalian and chick RNA interference. Nucleic Acids Res (2004) 32(3):936-948.
88. Amarzguioui M, Prydz H: An algorithm for selection of functional siRNA sequences. Biochem Biophys Res Commun (2004) 316(4):1050- 1058.
89. Hsieh AC, Bo R, Manola J, Vazquez F, Bare O, Khvorova A, Scaringe S, Sellers WR: A library of siRNA duplexes targeting the phosphoinositide 3-kinase pathway: Determinants of gene silencing for use in cell-based screens. Nucleic Acids Res (2004) 32(3):893-901.
90. Takasaki S, Kotani S, Konagaya A: An effective method for selecting siRNA target sequences in mammalian cells. Cell Cycle (2004) 3(6):790-795.
91. Poliseno L, Evangelista M, Mercatanti A, Mariani L, Citti L, Rainaldi G: The energy profiling of short interfering RNAs is highly predictive of their activity. Oligonucleotides (2004) 14(3):227-232.
92. Saetrom P, Snove O Jr: A comparison of siRNA efficacy predictors. Biochem Biophys Res Commun (2004) 321(1):247-253.
93. Chalk AM, Wahlestedt C, Sonnhammer EL: Improved and automated prediction of effective siRNA. Biochem Biophys Res Commun (2004) 319(1):264-274.
94. Huesken D, Lange J, Mickanin C, Weiler J, Asselbergs F, Warner J, Meloon B, Engel S, Rosenberg A, Cohen D, Labow M et al: Design of a genome-wide siRNA library using an artificial neural network. Nat Biotechnol (2005) 23(8):995-1001. • This paper presents the largest data set (to date) of functional siRNAs for structure-function analysis and utilizes an artificial neural network method of machine learning to predict active siRNA sites in new target sequences.
95. Huesken D, Lange J, Mickanin C, Weiler J, Asselbergs F, Warner J, Meloon B, Engel S, Rosenberg A, Cohen D, Labow M et al: Corrigendum: Design of a genome-wide siRNA library using an artificial neural network. Nat Biotechnol (2005) 23(10):1315.
96. Ge G, Wong GW, Luo B: Prediction of siRNA knockdown efficiency using artificial neural network models. Biochem Biophys Res Commun (2005) 336(2):723-728.
97. Jagla B, Aulner N, Kelly PD, Song D, Volchuk A, Zatorski A, Shum D, Mayer T, De Angelis DA, Ouerfelli O, Rutishauser U, Rothman JE: Sequence characteristics of functional siRNAs. RNA (2005) 11(6):864- 872.
98. Teramoto R, Aoki M, Kimura T, Kanaoka M: Prediction of siRNA functionality using generalized string kernel and support vector machine. FEBS Lett (2005) 579(13):2878-2882.
99. Jia P, Shi T, Cai Y, Li Y: Demonstration of two novel methods for predicting functional siRNA efficiency. BMC Bioinformatics (2006) 7:271.
100. Shabalina SA, Spiridonov AN, Ogurtsov AY: Computational models with thermodynamic and composition features improve siRNA design. BMC Bioinformatics (2006) 7:65.
101. Holen T: Efficient prediction of siRNAs with siRNA rules 1.0: An open-source JAVA approach to siRNA algorithms. RNA (2006) 12(9):1620-1625.
102. Vert JP, Foveau N, Lajaunie C, Vandenbrouck Y: An accurate and interpretable model for siRNA efficacy prediction. BMC Bioinformatics (2006) 7:520.
103. Gong W, Ren Y, Xu Q, Wang Y, Lin D, Zhou H, Li T: Integrated siRNA design based on surveying of features associated with high RNAi effectiveness. BMC Bioinformatics (2006) 7:516.
104. Ladunga I: More complete gene silencing by fewer siRNAs: Transparent optimized design and biophysical signature. Nucleic Acids Res (2007) 35(2):433-440.